Arabic Arabic English English French French German German
dark

Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1DARE-LARC1 Aims to Combine the Benefits of Long-acting Reversible Contraception with User-Controlled Flexibility to Pause or Resume Contraception as Desired

Daré Bioscience, Inc. today announced a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD) for $309,614. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Which programs are thriving for a five-star performer?

Next Post

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan

Related Posts
Total
0
Share